Risk Assessment of Failures in Generic Drug Development and Approval Procedure under Competitive Generic Drug Therapy and Patent Challenge Exclusivities Provided by the United States Food and Drug Administration
Language: English
Page range: 28 - 34
Submitted on: Dec 6, 2021
Accepted on: Mar 7, 2022
Published on: Apr 13, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2022 M Vivek Reddy, GNK Ganesh, B Babu, Ramesh Jagadeesan, Praharsh Kumar MR, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.